Emerging antibiotic resistance in Vibrio cholerae: a study of cholera prevalence and resistance patterns in Zambia's Copperbelt Province
- PMID: 40597869
- PMCID: PMC12220150
- DOI: 10.1186/s12879-025-11259-w
Emerging antibiotic resistance in Vibrio cholerae: a study of cholera prevalence and resistance patterns in Zambia's Copperbelt Province
Abstract
Introduction: Cholera remains a significant public health challenge in Zambia, particularly in the Copperbelt Province, where antibiotic-resistant Vibrio cholerae strains are increasingly threatening treatment efficacy. This study aimed to determine the prevalence of cholera and the antibiotic resistance patterns of V. cholerae isolates at three tertiary hospitals in the region.
Methods: A retrospective cross-sectional study was conducted across three major referral hospitals in the Copperbelt Province (Arthur Davison Children's Hospital, Kitwe Teaching Hospital, and Ndola Teaching Hospital) during the cholera outbreak from January to April 2024. Clinical samples from suspected cholera cases were analysed, and antimicrobial susceptibility testing was performed following Clinical Laboratory Standards Institute guidelines and the European committee on antimicrobial susceptibility testing methodology for Vibrio cholerae. To isolate Vibrio cholerae, alkaline peptone water and thiosulfate-citrate-bile salt-sucrose agar were utilized. The isolates were identified based on colony morphology, Gram staining, biochemical testing, and serotyping. Antimicrobial susceptibility testing was conducted by using the Kirby-Bauer disk diffusion method. Descriptive statistics were employed to assess the prevalence of Vibrio cholerae, and chi-square tests were applied with p-values of < 0.05 indicating statistical significance.
Results: Of the 892 suspected cases, 334 (37.4%) were confirmed as V. cholerae through culture. The highest number of V. cholerae confirmed cases was recorded at Ndola Teaching Hospital 221 (24.8%), followed by Kitwe Teaching Hospital 88 (9.9%), while Arthur Davison Children's Hospital 25 (2.8%) reported the lowest. High antimicrobial resistance was observed trimethoprim/sulfamethoxazole 69 (74.2%), ampicillin 75 (54.3%), and imipenem 22 (46.8%). In contrast, erythromycin 25 (100%), gentamicin 6 (85.7%) and ciprofloxacin 118 (76.6%) remained highly effective. The overall prevalence of multidrug resistance (MDR) in Vibrio cholerae was 3.7%. Among these, resistance to four or more antibiotics was observed in 3 (1.2%), followed by resistance to the combination of Ciprofloxacin, Ceftazidime, and Tetracycline in 2 (0.8%). All other MDR patterns were detected in a single isolate each (0.4%).
Conclusion: The high prevalence of antibiotic-resistant Vibrio cholerae in the Copperbelt Province underscores the urgent need for enhanced antimicrobial stewardship and robust surveillance systems to inform effective cholera control strategies. Sustainable public health impact can be achieved through targeted immunization campaigns in endemic areas combined with strengthened water, sanitation, and hygiene (WASH) interventions, including improved access to clean water, adequate sanitation infrastructure, hygiene promotion, and supportive policies, which are essential for reducing transmission and preventing future outbreaks in vulnerable populations. However, because the number of antibiotics used in antimicrobial susceptibility testing across isolates varies, these results should be interpreted cautiously. Such differences may affect the comparability and overall interpretation of resistance patterns.
Keywords: Vibrio cholerae; Antimicrobial stewardship; Cholera; Multidrug resistance; Zambia.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Ethical approval for this study was obtained from the Mulungushi University School of Medicine and Health Sciences Research Committee Board (IRB: 00012281, FWA: 0002888; Reference No. SMHS-MU1-2025-28) and the National Health Research Authority, Zambia (NHRA8108/25/02/2025) on February 25, 2025. Written informed consent was waived due to the retrospective nature of the study and the minimal risk posed to participants. To ensure confidentiality, patient information was anonymized, and all data were encrypted using encryption within the data collection and analysis tool. Access to the data was strictly restricted to the study authors through password-protected systems and minimizing the risk of unauthorized access or disclosure. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Global status of antimicrobial resistance among environmental isolates of Vibrio cholerae O1/O139: a systematic review and meta-analysis.Antimicrob Resist Infect Control. 2022 Apr 25;11(1):62. doi: 10.1186/s13756-022-01100-3. Antimicrob Resist Infect Control. 2022. PMID: 35468830 Free PMC article.
-
Pan-drug, colistin, streptomycin, erythromycin, clindamycin resistant Salmonella enterica serovars isolated from slaughtered cattle and human in mansoura, Egypt.Ann Clin Microbiol Antimicrob. 2025 Jul 3;24(1):40. doi: 10.1186/s12941-025-00809-4. Ann Clin Microbiol Antimicrob. 2025. PMID: 40611300 Free PMC article.
-
Antibiotic susceptibility patterns of Salmonella isolates from clinical, food, and environmental sources in Addis Ababa and surrounding towns, Ethiopia.Microbiol Spectr. 2025 Aug 5;13(8):e0097025. doi: 10.1128/spectrum.00970-25. Epub 2025 Jul 11. Microbiol Spectr. 2025. PMID: 40642986 Free PMC article.
-
Genomic characterization of Vibrio cholerae isolated from clinical and environmental sources during the 2022-2023 cholera outbreak in Kenya.Front Microbiol. 2025 Jul 7;16:1603736. doi: 10.3389/fmicb.2025.1603736. eCollection 2025. Front Microbiol. 2025. PMID: 40693147 Free PMC article.
-
Interventions to improve antibiotic prescribing practices for hospital inpatients.Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4. Cochrane Database Syst Rev. 2017. PMID: 28178770 Free PMC article.
References
-
- WHO. Data show marked increase in annual cholera deaths. World Health Organ WHOn. 2024;481–95.
-
- Gething PW, Ayling S, Mugabi J, Muximpua OD, Kagulura SS, Joseph G. M Jeuland editor 2023 Cholera risk in lusaka: A Geospatial analysis to inform improved water and sanitation provision. PLOS Water 2 e0000163.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous